1. Sohinki D, Obel OA. Current trends in supraventricular tachycardia management. Ochsner J. 2014;14(4):586–95.
2. Rehorn M, Sacks NC, Emden MR, et al. Prevalence and incidence of patients with paroxysmal supraventricular tachycardia in the United States. J Cardiovasc Electrophysiol. 2021;32:2199–206. https://doi.org/10.1111/jce.15109.
3. Anon. Paroxysmal supraventricular tachycardia (PSVT). Johns Hopkins Medicine. 2020. https://www.hopkinsmedicine.org/health/conditions-and-diseases/paroxysmal-supraventricular-tachycardia. Accessed 8 May 2023.
4. Hafeez Y, Quintanilla Rodriguez BS, Ahmed I, et al. Paroxysmal Supraventricular Tachycardia. [Updated 2023 Feb 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK507699/.
5. Elliott WJ, Ram CV. Calcium channel blockers. J Clin Hypertens (Greenwich). 2011;13(9):687–9. https://doi.org/10.1111/j.1751-7176.2011.00513.x.